NuVasive, Inc. Buyback
OLI recorded this information on 10/24/2017
NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that its Board of Directors approved a share repurchase program authorizing the purchase of up to $100 million of the Company's common stock over a three-year period commencing October 25, 2017.
Nuvasive is a medical device company focused on developing minimally disruptive surgical products and procedurally integrated solutions for spine surgery. Co.'s principal product offering includes a minimally disruptive surgical platform, Maximum Access Surgery. The platform includes Co.'s proprietary software-driven nerve detection and avoidance systems, and Intraoperative Monitoring services and support; MaXcess, an integrated split-blade retractor system; and implants and biologics. Co.'s spine surgery product line offerings, which include products for the thoracolumbar and the cervical spine, are used to enable surgeon access to the spine to perform restorative and fusion procedures.
NUVA SEC Filing Email Alerts Service
Open the NUVA Page at The Online Investor »
Hold (2.47 out of 4)